Hazards of Diagnostic and Therapeutic Use of Radioactive Iodines in Thyroid Disorders
  Report of the 24th Annual Meeting of the European Thyroid Association

Per Hall, M. D., Ph. D.
Department of Cancer Epidemiology, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden

Introduction
Radiation-associated cancer
Cancer risks after diagnostic doses of radioiodine
Cancer risk after 131I treatment for hyperthyroidism
Cancer risk after 131I treatment for thyroid cancer
The Chernobyl accident
Conclusion
Author
References